Detection and localization of surgically resectable cancers with a multi-analyte blood test

Cohen, Joshua D., Li, Lu, Wang, Yuxuan, Thoburn, Christopher, Afsari, Bahman, Danilova, Ludmila, Douville, Christopher, Javed, Ammar A. +34 more·2018·Science

Cited by (1,003)

Items 801–900 of 1,003

  1. Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case–control study
    Jinke Sui, Xianrui Wu, Chenyang Wang, Guoqiang Wang, Chengcheng Li, Jing Zhao, Yuzi Zhang, Jianxing Xiang, Yu Xu, Weiqi Nian et al. · 2021 · Clinical Epigenetics
  2. Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA
    Giorgio Patelli, Caterina Vaghi, Federica Tosi, Gianluca Mauri, Alessio Amatu, Daniela Massihnia, Silvia Ghezzi, Erica Francesca Bonazzina, Katia Bruna Bencardino, Giulio Cerea et al. · 2021 · Targeted Oncology
  3. Nasopharyngeal Carcinoma and Its Association with Epstein-Barr Virus
    Harish N. Vasudevan, Sue Sun Yom · 2021 · Hematology/Oncology Clinics of North America
  4. Protein detection in blood with single-molecule imaging
    Chih-Ping Mao, Shih-Chin Wang, Yu‐Ping Su, Ssu-Hsueh Tseng, Liangmei He, Annie A. Wu, Richard B. S. Roden, Jie Xiao, Chien‐Fu Hung · 2021 · Science Advances
  5. A Rapid and Facile Separation–Detection Integrated Strategy for Exosome Profiling Based on Boronic Acid-Directed Coupling Immunoaffinity
    Yiting Wang, Ming-Di Cai, Lili Sun, Ruinian Hua · 2021 · Analytical Chemistry
  6. Circulating Tumor DNA Profiling From Breast Cancer Screening Through to Metastatic Disease
    Karen Page, Luke J. Martinson, Daniel Fernández-García, Allison Hills, Kelly L. T. Gleason, Molly C. Gray, Amelia J. Rushton, Georgios Nteliopoulos, Robert K. Hastings, Kate S. Goddard et al. · 2021 · JCO Precision Oncology
  7. Opportunities for Early Cancer Detection: The Rise of ctDNA Methylation-Based Pan-Cancer Screening Technologies
    Nicolas Constantin, Abu Ali Ibn Sina, Darren J. Korbie, Matt Trau · 2022 · Epigenomes
  8. Cancer Diagnostics and Early Detection Using Electrochemical Aptasensors
    Joel I. Omage, Ethan Easterday, Jelonia Tasha Rumph, Imamulhaq Brula, Braxton Hill, Jeffrey Kristensen, Dat Thinh Ha, Cristi Lara Galindo, Michael K. Danquah, Naiya Sims et al. · 2022 · Micromachines
  9. Molecular Computation for Molecular Classification
    Coline Kieffer, Anthony J. Genot, Yannick Rondelez, Guillaume Gines · 2023 · Advanced Biology
  10. Circulating Tumor DNA in the Management of Early-Stage Breast Cancer
    Katerina Vlataki, Sevastiani Antonouli, Christina Kalyvioti, Evangeli S. Lampri, Sevasti Kamina, Davide Mauri, Haralampos V. Harissis, Angeliki Magklara · 2023 · Cells
  11. Biomarkers in lung cancer screening: a narrative review
    Hannah N. Marmor, J. Tyler Zorn, Stephen A. Deppen, Pierre P. Massion, Eric L. Grogan · 2023 · Current Challenges in Thoracic Surgery
  12. Artificial Intelligence in cancer epigenomics: a review on advances in pan-cancer detection and precision medicine
    Karishma Sahoo, Prakash Lingasamy, Masuma Khatun, Sajitha Lulu Sudhakaran, Andres Salumets, Vino Sundararajan, Vijayachitra Modhukur · 2025 · Epigenetics & Chromatin
  13. Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma
    Francesco Gatto, Kyle A. Blum, Seyedeh Shaghayegh Hosseini, Mazyar Ghanaat, Mahyar Y. Kashan, Francesca Maccari, Fabio Galeotti, James J.-D. Hsieh, Nicola Volpi, A. Ari Hakimi et al. · 2018 · European Urology Oncology
  14. Advanced antifouling zwitterionic layer based impedimetric HER2 biosensing in human serum: Glycoprofiling as a novel approach for breast cancer diagnostics
    Erika Chocholova, Tomáš Bertók, Lenka Lorencová, Alena Holazová, Pavol Farkaš, Alica Vikartovská, Vladimír Bella, Darina Velicova, Peter Kasák, Anita Eckstein Andicsová et al. · 2018 · Sensors and Actuators B Chemical
  15. Glycomics of prostate cancer: updates
    Jan Tkáč, Tomáš Bertók, Michal Híreš, Eduard Jáné, Lenka Lorencová, Peter Kasák · 2018 · Expert Review of Proteomics
  16. Time to abandon early detection cancer screening
    Hans‐Olov Adami, Mette Kalager, Unnur Anna Valdimarsdóttir, Michael Bretthauer, John P. A. Ioannidis · 2018 · European Journal of Clinical Investigation
  17. Cancer Treatment in the Genomic Era
    Gary Joseph Doherty, Michele Petruzzelli, Emma J. Beddowes, Saif S. Ahmad, Carlos Caldas, Richard J. Gilbertson · 2019 · Annual Review of Biochemistry
  18. Circulating cell-free tumor DNA analysis in pediatric cancers
    Daniel Andersson, Henrik Fagman, Martin G. Dalin, Anders Ståhlberg · 2019 · Molecular Aspects of Medicine
  19. WDR74 induces nuclear β-catenin accumulation and activates Wnt-responsive genes to promote lung cancer growth and metastasis
    Yumei Li, Fan Chen, Weiyu Shen, Bifei Li, Rong Xiang, Lijuan Qu, Chen Zhang, Li Gao, Huanzhang Xie, Vladimir L. Katanaev et al. · 2019 · Cancer Letters
  20. Plasma-Derived Extracellular Vesicles Convey Protein Signatures That Reflect Pathophysiology in Lung and Pancreatic Adenocarcinomas
    Johannes Francois Fahrmann, Xiangying Mao, Ehsan Irajizad, Hiroyuki Katayama, Michela Capello, Ichidai Tanaka, Taketo Kato, Ignacio Ivan Wistuba, Anirban Maitra, Edwin Justin Ostrin et al. · 2020 · Cancers
  21. Circulating tumor DNA in lung cancer: real-time monitoring of disease evolution and treatment response
    Ruiyu Li, Zhi-Yong Liang · 2020 · Chinese Medical Journal
  22. Current Status and Future Perspectives of Liquid Biopsy in Small Cell Lung Cancer
    Patricia Mondelo‐Macía, Jorge García, Luis León‐Mateos, Adrián Castillo‐García, Rafael López‐López, Laura Muinelo‐Romay, Roberto Díaz‐Peña · 2021 · Biomedicines
  23. Circular RNAs Are Promising Biomarkers in Liquid Biopsy for the Diagnosis of Non-small Cell Lung Cancer
    Lanxiang Huang, Yuan Rong, Xuan Tang, Kezhen Yi, Jianyuan Wu, Fubing Wang · 2021 · Frontiers in Molecular Biosciences
  24. Using artificial intelligence in a primary care setting to identify patients at risk for cancer: a risk prediction model based on routine laboratory tests
    Patricia Diana Sørensen, Henry Christensen, Søren Worsøe Laursen, Christian Hardahl, Ivan Brandslund, Jonna Skov Madsen · 2021 · Clinical Chemistry and Laboratory Medicine (CCLM)
  25. Accelerating the Development and Validation of Liquid Biopsy for Early Cancer Screening and Treatment Tailoring
    Denis Horgan, Tanja Čufer, Francesco Gatto, Iwona A. Lugowska, Donatella Verbanac, Ângela Carvalho, Jonathan A. Lal, Marta Kozaric, Sinéad Toomey, Hristo Yordanov Ivanov et al. · 2022 · Healthcare
  26. Clinical application of molecular residual disease detection by circulation tumor DNA in solid cancers and a comparison of technologies: review article
    Qiantong Dong, Chenbin Chen, Yuanbo Hu, Weiteng Zhang, Xinxin Yang, Yingxue Qi, Chan Zhu, Xiaodong Chen, Xian Shen, Weiping Ji · 2023 · Cancer Biology & Therapy
  27. Liquid biopsy: An arsenal for tumour screening and early diagnosis
    Qi Zhang, Xiaoli Zhang, Peipei Xie, Wen Zhang · 2024 · Cancer Treatment Reviews
  28. Clinical Utility of Tumor-Naïve Presurgical Circulating Tumor DNA Detection in Early-Stage NSCLC
    Tae Hee Hong, Soohyun Hwang, Abhijit Dasgupta, Christopher Abbosh, Tiffany Hung, Joerg Bredno, Jill Walker, Xiaojin Shi, Tsveta Milenkova, Leora Horn et al. · 2024 · Journal of Thoracic Oncology
  29. Lung cancer screening: where do we stand?
    Georgia F. Hardavella, Armin Frille, Katherina Bernadette Sreter, Florence Atrafi, Uraujh Yousaf-Khan, Ferhat Beyaz, Fotis Kyriakou, Elena Bellou, Monica L.L. Mullin, Sam M. Janes · 2024 · Breathe
  30. Role of circulating tumor DNA in the management of early‐stage lung cancer
    Heng Zhao, Kezhong Chen, Bengang Hui, Kai Zhang, Fan Yang, Jun Wang · 2018 · Thoracic Cancer
  31. Serum Biomarker Based Algorithms in Diagnosis of Ovarian Cancer: A Review
    Suchitra Kumari · 2018 · Indian Journal of Clinical Biochemistry
  32. Recent advances in colorectal cancer screening
    Dan Li · 2018 · Chronic Diseases and Translational Medicine
  33. Towards an Organ-Sparing Approach for Locally Advanced Esophageal Cancer
    Berend J. van der Wilk, Ben M. Eyck, Manon C.W. Spaander, Roelf Valkema, Sjoerd M. Lagarde, Bas P. L. Wijnhoven, J. Jan B. van Lanschot · 2018 · Digestive Surgery
  34. Diagnosis of epithelial ovarian cancer using a combined protein biomarker panel
    Matthew R. Russell, Ciaren Graham, Alfonsina D’Amato, Aleksandra Gentry‐Maharaj, Andy Ryan, Jatinderpal Kalsi, Anthony David Whetton, Usha Menon, Ian J. Jacobs, Robert L. J. Graham · 2019 · British Journal of Cancer
  35. The potential of ctDNA analysis in breast cancer
    Eleni Tzanikou, Evi S. Lianidou · 2019 · Critical Reviews in Clinical Laboratory Sciences
  36. Recurrent PTPRT/JAK2 mutations in lung adenocarcinoma among African Americans
    Khadijah A. Mitchell, Noah Nichols, Wei Tang, Jennifer Walling, Holly S. Stevenson, Marbin A. Pineda, Roxana Stefanescu, Daniel C. Edelman, Andrew T. Girvin, Adriana Zingone et al. · 2019 · Nature Communications
  37. Development of circulating tumour DNA analysis for gastrointestinal cancers
    Yoshiaki Nakamura, Kohei Shitara · 2020 · ESMO Open
  38. Circulating miRNAs as Biomarkers in Aggressive B Cell Lymphomas
    Esther E.E. Drees, Dirk Michiel Pegtel · 2020 · Trends in cancer
  39. Comprehensive Gene Mutation Profiling of Circulating Tumor DNA in Ovarian Cancer: Its Pathological and Prognostic Impact
    Tomoko Noguchi, Naoyuki Iwahashi, Kazuko Sakai, Kaho Matsuda, Hitomi Matsukawa, Saori Toujima, Kazuto Nishio, Kazuhiko Ino · 2020 · Cancers
  40. Development of nanosensor by bioorthogonal reaction for multi-detection of the biomarkers of hepatocellular carcinoma
    Dehua Hu, Lina Yang, Suimin Deng, Yun Hao, Kaina Zhang, Xiangfeng Wang, Yuan Liu, Hailing Liu, Yiping Chen, Mengxia Xie · 2021 · Sensors and Actuators B Chemical
  41. imPlatelet classifier: image‐converted RNA biomarker profiles enable blood‐based cancer diagnostics
    Krzysztof Pastuszak, Anna Maria Supernat, Myron G. Best, Sjors G. J. G. In ‘t Veld, Sylwia Łapińska‐Szumczyk, Anna Łojkowska, Robert Różański, Anna Joanna Zaczek, Jacek Jassem, Thomas D. Wurdinger et al. · 2021 · Molecular Oncology
  42. Porous Inorganic Materials for Bioanalysis and Diagnostic Applications
    Xun Liu, Naikun Song, Dahong Qian, Sai Gu, Jun Pu, Lin Huang, Jian Liu, Kun Qian · 2021 · ACS Biomaterials Science & Engineering
  43. Site-specific therapy in cancers of unknown primary site: a systematic review and meta-analysis
    Yue Ding, Junjie Jiang, J. Xu, Yinglin Chen, Yaru Zheng, Weiqin Jiang, Chenyu Mao, Hai‐yin Jiang, X. Bao, Y. Shen et al. · 2022 · ESMO Open
  44. Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer
    Ulf B Gyllensten, Julia Hedlund‐Lindberg, Johanna Svensson, Johanna Manninen, Torbjörn Öst, Jon Ramsell, Matilda Åslin, Emma L. Ivansson, Marta I. Lomnytska, Maria Lycke et al. · 2022 · Cancers
  45. Liquid biopsy-based decision support algorithms for diagnosis and subtyping of lung cancer
    Esther Visser, Sylvia A. A. M. Genet, Remco de Kock, Ben E.E.M. van den Borne, Maggy Youssef-El Soud, Huub N. A. Belderbos, Gerben Stege, Marleen E.A. de Saegher, Susan C. van ‘t Westeinde, Luc Brunsveld et al. · 2023 · Lung Cancer
  46. Bridging horizons beyond CIRCULATE-Japan: a new paradigm in molecular residual disease detection via whole genome sequencing-based circulating tumor DNA assay
    Tadayoshi Hashimoto, Yoshiaki Nakamura, Eiji Oki, Shin Kobayashi, Junichiro Yuda, Taro Shibuki, Hideaki Bando, Takayuki Yoshino · 2024 · International Journal of Clinical Oncology
  47. Multimodal cell-free DNA whole-genome TAPS is sensitive and reveals specific cancer signals
    Dimitris V. Vavoulis, Anthony Cutts, Nishita Thota, Jordan Brown, Robert Sugar, Antonio Rueda, Arman Ardalan, Kieran Howard, Flavia Matos Santo, Thippesh Sannasiddappa et al. · 2025 · Nature Communications
  48. Early Detection of Pancreatic Cancer: Current Advances and Future Opportunities
    Zijin Lin, Esther A. Adeniran, Yanna Cai, Touseef Ahmad Qureshi, Debiao Li, Jun Gong, Jianing Li, Stephen Jacob Pandol, Yi Jiang · 2025 · Biomedicines
  49. The role of transvaginal ultrasound in screening for ovarian cancer
    Stuart C. Campbell, Aleksandra Gentry‐Maharaj · 2018 · Climacteric
  50. Mutated clones are the new normal
    Cristian Tomasetti · 2019 · Science
  51. New approaches for detecting cancer with circulating cell-free DNA
    Clare Fiala, Eleftherios P. Diamandis · 2019 · BMC Medicine
  52. Comparison of Target Enrichment Platforms for Circulating Tumor DNA Detection
    So Ngo Lam, Ying Zhou, Yee Man Chan, Ching Man Foo, Po Yi Lee, Wing Yeung Mok, Wing Sum Wong, Yan Yee Fung, Kit Yee Wong, Jun Yuan Huang et al. · 2020 · Scientific Reports
  53. Improving Multi-Tumor Biomarker Health Check-Up Tests with Machine Learning Algorithms
    Hsin‐Yao Wang, Chun-Hsien Chen, Steve Shi, Chia‐Ru Chung, Ying-Hao Wen, Min‐Hsien Wu, Michael Lebowitz, Jiming Zhou, Jang‐Jih Lu · 2020 · Cancers
  54. A Multi-Analyte Approach for Improved Sensitivity of Liquid Biopsies in Prostate Cancer
    Lilli Hofmann, Katja Sallinger, Christoph Walter Haudum, Maria Anna Smolle, Ellen Heitzer, Tina Moser, Michael Novy, Kevin Gesson, Thomas Kroneis, Thomas Bauernhofer et al. · 2020 · Cancers
  55. Detection and Diagnostic Utilization of Cellular and Cell-Free Tumor DNA
    Jonathan C. Dudley, Maximilian Diehn · 2020 · Annual Review of Pathology Mechanisms of Disease
  56. Multi‐biomarker panel prediction model for diagnosis of pancreatic cancer
    Doo‐Ho Lee, Woongchang Yoon, Areum Lee, Youngmin Han, Yoonhyeong Byun, Jae Seung Kang, Hongbeom Kim, Wooil Kwon, Young‐Ah Suh, Yonghwan Choi et al. · 2021 · Journal of Hepato-Biliary-Pancreatic Sciences
  57. Ultrasensitive SQDs-based electrochemiluminescence assay for determination of miRNA-141 with dual-amplification of co-reaction accelerators and DNA walker
    Kailun Ji, Yifei Wang, Lebao Mao, Yuzhe Wang, Xun Zhang · 2021 · Sensors and Actuators B Chemical
  58. Recent progress in the development of aptasensors for cancer diagnosis: Focusing on aptamers against cancer biomarkers
    Somayeh Vandghanooni, Zohreh Sanaat, Raheleh Farahzadi, Morteza Eskandani, Hossein Omidian, Yadollah Omidi · 2021 · Microchemical Journal
  59. A novel method for liquid-phase extraction of cell-free DNA for detection of circulating tumor DNA
    Filip Jankú, Helen J. Huang, David Y. Pereira, Masae Kobayashi, Chung Hei Chiu, S. Greg Call, Kristen T. Woodbury, Felix C. Chao, Daniel R. Marshak, Ricky Y. T. Chiu · 2021 · Scientific Reports
  60. Circulating Tumor DNA Allele Fraction
    Joerg Bredno, Oliver Venn, Xiaoji Chen, Peter Freese, Joshua J. Ofman · 2022 · American Journal Of Pathology
  61. Methylation in cell-free DNA for early cancer detection
    Ferran Fece de la Cruz, Ryan Bruce Corcoran · 2018 · Annals of Oncology
  62. Cancer associated macrophage-like cells and prognosis of esophageal cancer after chemoradiation therapy
    Daniel J. Gironda, Daniel L. Adams, Jianzhong He, Ting Xu, Hui Gao, Yawei Qiao, Ritsuko R. Komaki, James Mwikya Reuben, Zhongxing X. Liao, Mariela A. Blum-Murphy et al. · 2020 · Journal of Translational Medicine
  63. Serum biomarker-based early detection of pancreatic ductal adenocarcinomas with ensemble learning
    Nuno Rocha Nene, Alexander Ney, Tatiana Nazarenko, Oleg B. Blyuss, Harvey E. Johnston, Harry J. Whitwell, Eva Sedlak, Aleksandra Gentry‐Maharaj, Sophia Apostolidou, Eithne Costello et al. · 2023 · Communications Medicine
  64. Effective enrichment of trace exosomes for the label-free SERS detection via low-cost thermophoretic profiling
    Yu Yang Guo, Ruiyuan Zhang, Hongjun You, Jixiang Fang · 2024 · Biosensors and Bioelectronics
  65. Second Primary Lung Cancer – An Emerging Issue in Lung Cancer Survivors
    Sarah Østrup Jensen, David Allan Moore, Arif Anwer Surani, Philip A.J. Crosbie, Nitzan Rosenfeld, Robert Campbell Rintoul · 2024 · Journal of Thoracic Oncology
  66. Transformer-based AI technology improves early ovarian cancer diagnosis using cfDNA methylation markers
    Gen Li, Yongqiang Zhang, Kun Li, Xiaohong Liu, Yaping Lu, Zhenlin Zhang, Zhihai Liu, Yong Wu, Fei Liu, Hong Dong Huang et al. · 2024 · Cell Reports Medicine
  67. Mining nucleic acid “omics” to boost liquid biopsy in cancer
    Ann Tivey, Rebecca J. Lee, Alexandra Clipson, Steven M. Hill, Paul C. Lorigan, Dominic G. Rothwell, Caroline Dive, Florent C. Mouliere · 2024 · Cell Reports Medicine
  68. Fragmentomics profiling and quantification of plasma Epstein-Barr virus DNA enhance prediction of future nasopharyngeal carcinoma
    W.K. Lam, Guannan Kang, Charles Ming Lok Chan, Vicky C.T. Lee, Mary-Jane L. Ma, Qing Xiao Zhou, Peiyong Jiang, Irene O L Tse, Ann Dorothy King, Kenneth C.W. Wong et al. · 2025 · Cancer Cell
  69. Bioinformatics Tools and Workflow to Select Blood Biomarkers for Early Cancer Diagnosis: An Application to Pancreatic Cancer
    Yves Vandenbrouck, David Christiany, Florence Combes, Valentin Loux, Virginie Brun · 2019 · PROTEOMICS
  70. Cell‑free DNA as a liquid biopsy for early detection of gastric cancer (Review)
    Zhengbin Huang, Haitao Zhang, Benjamin P. Yu, De-Hua Yu · 2020 · Oncology Letters
  71. Circulating Biomarkers for Early Stage Non-Small Cell Lung Carcinoma Detection: Supplementation to Low‐Dose Computed Tomography
    Chin Fung Kelvin Kan, Graham D. Unis, Luke Z. Li, Susan Gunn, Li Li, H. Peter Soyer, Mitchell S. Stark · 2021 · Frontiers in Oncology
  72. Next steps in the early detection of ovarian cancer
    Robert C. Bast, Chae Young Han, Zhen Lü, Karen H. Lu · 2021 · Communications Medicine
  73. Imaging immunity in patients with cancer using positron emission tomography
    Fiona Hegi‐Johnson, Stacey E. Rudd, Rodney J. Hicks, Dirk De Ruysscher, Joseph A. Trapani, Thomas John, Paul S. Donnelly, Benjamin J. Blyth, Gerard G. Hanna, Sarah Everitt et al. · 2022 · npj Precision Oncology
  74. Glycomics meets artificial intelligence – Potential of glycan analysis for identification of seropositive and seronegative rheumatoid arthritis patients revealed
    Erika Chocholova, Tomáš Bertók, Eduard Jáné, Lenka Lorencová, Alena Holazová, Ludmila Belicka, Štefan Belický, Danica Mislovičová, Alica Vikartovská, Richard Imrich et al. · 2018 · Clinica Chimica Acta
  75. Liquid biopsy for cancer management: a revolutionary but still limited new tool for precision medicine
    María Arechederra, Matias Antonio Avila, Carmen Berasain · 2020 · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio
  76. Role of AI in empowering and redefining the oncology care landscape: perspective from a developing nation
    Goel, Isha, Bhaskar, Yogendra, Kumar, Nand, Singh, Sunil, Amanullah, Mohammed, Dhar, Ruby, Karmakar, Subhradip · 2025 · Frontiers in Digital Health
  77. Development of a blood-based extracellular vesicle classifier for detection of early-stage pancreatic ductal adenocarcinoma
    Juan Pablo Hinestrosa, Rosalie C. Sears, Harmeet Dhani, Jean M. Lewis, Gregor Schroeder, Heath I. Balcer, Dove Keith, Brett C. Sheppard, Razelle Kurzrock, Paul R. Billings · 2023 · Communications Medicine
  78. Multi-cancer risk stratification based on national health data: a retrospective modelling and validation study
    Alexander W. Jung, Peter Christoffer Holm, Kumar Gaurav, Jessica Xin Hjaltelin, Davide Placido, Laust Hvas Mortensen, Ewan Birney, S⊘ren Brunak, Moritz Gerstung · 2024 · The Lancet Digital Health
  79. Harnessing DNA computing and nanopore decoding for practical applications: from informatics to microRNA-targeting diagnostics
    Sotaro Takiguchi, Nanami Takeuchi, Vasily Shenshin, Guillaume Gines, Anthony J. Genot, Jeff Nivala, Yannick Rondelez, Ryuji Kawano · 2024 · Chemical Society Reviews
  80. Multi-cancer early detection tests for general population screening: a systematic literature review
    Ros Wade, Sarah J Nevitt, Yiwen Liu, Melissa Harden, Claire Khouja, Gary Raine, Rachel C. Churchill, Sofia Dias · 2024 · Health Technology Assessment
  81. Enhanced Early Detection of Colorectal Cancer via Blood Biomarker Combinations Identified Through Extracellular Vesicle Isolation and Artificial Intelligence Analysis
    Bonhan Koo, Young Il Kim, Minju Lee, Seok‐Byung Lim, Yong Moon Shin · 2025 · Journal of Extracellular Vesicles
  82. Versatile graphene biosensors for enhancing human cell therapy
    George Mihail Vlăsceanu, Roxana-Maria Amărandi, Mariana Ioniţă, Teddy Tite, Horia Iovu, Luisa N. Pilan, Jorge Sans Burns · 2018 · Biosensors and Bioelectronics
  83. A feasibility study of colorectal cancer diagnosis via circulating tumor DNA derived CNV detection
    Bhuvan Molparia, Glenn Oliveira, Jennifer L. Wagner, Emily G. Spencer, Ali Torkamani · 2018 · PLoS ONE
  84. Circulating-Free DNA Analysis in Hepatocellular Carcinoma: A Promising Strategy to Improve Patients’ Management and Therapy Outcomes
    Silvia Mezzalira, Elena De Mattia, Michela Guardascione, Chiara Dalle Fratte, Erika Cecchin, Giuseppe Toffoli · 2019 · International Journal of Molecular Sciences
  85. Liquid biopsy approaches for pleural effusion in lung cancer patients
    Gayathri Baburaj, Rama Rao Damerla, Karthik Udupa, Preetiparna Parida, Murali Munisamy, Jill Kolesar, Mahadev Rao · 2020 · Molecular Biology Reports
  86. Can a Broad Molecular Screen Based on Circulating Tumor DNA Aid in Early Cancer Detection?
    Clare Fiala, Eleftherios P. Diamandis · 2020 · The Journal of Applied Laboratory Medicine
  87. The Potential of Circular RNAs as Cancer Biomarkers
    Jason R. Brown, Arul M. Chinnaiyan · 2020 · Cancer Epidemiology Biomarkers & Prevention
  88. Alu cell-free DNA concentration, Alu index, and LINE-1 hypomethylation as a cancer predictor
    Min‐Koo Park, Jeong-Chan Lee, Ji‐Won Lee, Sungjoo Hwang · 2021 · Clinical Biochemistry
  89. Plasma Circulating Tumor DNA Sequencing Predicts Minimal Residual Disease in Resectable Esophageal Squamous Cell Carcinoma
    Tao Liu, Qianqian Yao, Hai Dan Jin · 2021 · Frontiers in Oncology
  90. Recent Advances in Pediatric Cancer Research
    Troy A. McEachron, Lee J. Helman · 2021 · Cancer Research
  91. Early detection and stratification of lung cancer aided by a cost-effective assay targeting circulating tumor DNA (ctDNA) methylation
    Zhoufeng Wang, Kehui Xie, Guonian Zhu, Chengcheng Ma, Cheng Cheng, Yangqian Li, Xue Xiao, Chengpin Li, Jun Tang, Hui Wang et al. · 2023 · Respiratory Research
  92. Plasma Epstein–Barr Virus DNA and Risk of Future Nasopharyngeal Cancer
    K.C. Allen Chan, W.K. Lam, Ann Dorothy King, Vivien S. Lin, Patrick P.H. Lee, Benny Chung-Ying Zee, Stephen Lam Chan, Irene O L Tse, Amy F. C. Tsang, Maggie Z. J. Li et al. · 2023 · NEJM Evidence
  93. One size does not fit all: Size-based plasma DNA diagnostics
    Ellen Heitzer, Michael R. Speicher · 2018 · Science Translational Medicine
  94. Early detection of the PAX3‐FOXO1 fusion gene in circulating tumor‐derived DNA in a case of alveolar rhabdomyosarcoma
    Minenori Eguchi‐Ishimae, Mari Tezuka, Tomoki Kokeguchi, Kozo Nagai, Kyoko Moritani, Sachiko Yonezawa, Hisamichi Tauchi, Kiriko Tokuda, Yasushi Ishida, Eiichi Ishii et al. · 2019 · Genes Chromosomes and Cancer
  95. Coimmunocapture and Electrochemical Quantitation of Total and Phosphorylated Amyloid-β 40 Monomers
    Zhenzhen Yin, Shuhui Wang, Baochai Shen, Chunyan Deng, Qiuyun Tu, Yan Jin, Lu Hua Shen, Bin Jiao, Juan Xiang · 2019 · Analytical Chemistry
  96. Precision gynecologic oncology: circulating cell free DNA epigenomic analysis, artificial intelligence and the accurate detection of ovarian cancer
    Ray O Bahado-Singh, Amin Ibrahim, Zaid R. Al-Wahab, Buket Aydas, Uppala Radhakrishna, Ali Yılmaz, Sangeetha Vishweswaraiah · 2022 · Scientific Reports
  97. Assessing the Clinical Utility of Liquid Biopsies Across 5 Potential Indications From Therapy Selection to Population Screening
    David J. Carr, H. Gilbert Welch · 2023 · JAMA Internal Medicine
  98. Principles of digital sequencing using unique molecular identifiers
    Daniel Andersson, Firaol Tamiru Kebede, Mandy Escobar, Tobias Österlund, Anders Ståhlberg · 2024 · Molecular Aspects of Medicine
  99. Nonequilibrium hybridization-driven CRISPR/Cas adapter with extended energetic penalty for discrimination of single-nucleotide variants
    Qiong Liu, Jiang Zhou, Shengli Li, Yinfeng Li, Yingfei Wan, Zhenyu Hu, Shimeng Ma, Zhen Zou, Ronghua Yang · 2025 · Nucleic Acids Research
  100. The coming era of proteomics-driven precision medicine
    Ying Jiang, Jian Wang, Aihua Sun, Hongxing Zhang, Xiaobo Yu, Weijie Qin, Wantao Ying, Yanchang Li, Cheng Chang, Xiaowen Wang et al. · 2025 · National Science Review